chr7-124892326-T-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_015450.3(POT1):​c.64A>G​(p.Ile22Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000252 in 1,539,338 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I22T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 0 hom. )

Consequence

POT1
NM_015450.3 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:5

Conservation

PhyloP100: -1.13

Publications

3 publications found
Variant links:
Genes affected
POT1 (HGNC:17284): (protection of telomeres 1) This gene is a member of the telombin family and encodes a nuclear protein involved in telomere maintenance. Specifically, this protein functions as a member of a multi-protein complex that binds to the TTAGGG repeats of telomeres, regulating telomere length and protecting chromosome ends from illegitimate recombination, catastrophic chromosome instability, and abnormal chromosome segregation. Increased transcriptional expression of this gene is associated with stomach carcinogenesis and its progression. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
POT1 Gene-Disease associations (from GenCC):
  • pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • tumor predisposition syndrome 3
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • glioma susceptibility 9
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • thyroid gland carcinoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • cerebroretinal microangiopathy with calcifications and cysts 3
    Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.027004272).
BP6
Variant 7-124892326-T-C is Benign according to our data. Variant chr7-124892326-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 436392.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000185 (28/151670) while in subpopulation NFE AF = 0.00034 (23/67642). AF 95% confidence interval is 0.000232. There are 0 homozygotes in GnomAd4. There are 13 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015450.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POT1
NM_015450.3
MANE Select
c.64A>Gp.Ile22Val
missense
Exon 6 of 19NP_056265.2Q9NUX5-1
POT1
NM_001042594.2
c.-199A>G
5_prime_UTR
Exon 6 of 18NP_001036059.1A8MTK3
POT1
NR_003102.2
n.507A>G
non_coding_transcript_exon
Exon 6 of 20

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POT1
ENST00000357628.8
TSL:2 MANE Select
c.64A>Gp.Ile22Val
missense
Exon 6 of 19ENSP00000350249.3Q9NUX5-1
POT1
ENST00000607932.5
TSL:1
n.64A>G
non_coding_transcript_exon
Exon 2 of 14ENSP00000476506.1Q5MJ34
POT1
ENST00000608057.5
TSL:1
n.64A>G
non_coding_transcript_exon
Exon 2 of 16ENSP00000476371.1Q5MJ35

Frequencies

GnomAD3 genomes
AF:
0.000185
AC:
28
AN:
151552
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000340
Gnomad OTH
AF:
0.000481
GnomAD2 exomes
AF:
0.000160
AC:
30
AN:
187696
AF XY:
0.000175
show subpopulations
Gnomad AFR exome
AF:
0.0000859
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000973
Gnomad NFE exome
AF:
0.000292
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000259
AC:
360
AN:
1387668
Hom.:
0
Cov.:
29
AF XY:
0.000253
AC XY:
174
AN XY:
688876
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
28342
American (AMR)
AF:
0.00
AC:
0
AN:
28652
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24058
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74206
European-Finnish (FIN)
AF:
0.0000569
AC:
3
AN:
52736
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5556
European-Non Finnish (NFE)
AF:
0.000326
AC:
353
AN:
1082648
Other (OTH)
AF:
0.0000698
AC:
4
AN:
57276
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
16
32
49
65
81
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000185
AC:
28
AN:
151670
Hom.:
0
Cov.:
32
AF XY:
0.000175
AC XY:
13
AN XY:
74144
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41488
American (AMR)
AF:
0.00
AC:
0
AN:
15154
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000340
AC:
23
AN:
67642
Other (OTH)
AF:
0.000476
AC:
1
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000351
Hom.:
0
Bravo
AF:
0.000166
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000132
AC:
16

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
not provided (3)
-
2
1
not specified (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
1
-
Tumor predisposition syndrome 3 (1)
-
1
-
Tumor predisposition syndrome 3;C5830496:Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8;C5830497:Cerebroretinal microangiopathy with calcifications and cysts 3 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.40
DANN
Benign
0.36
DEOGEN2
Benign
0.34
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.050
N
LIST_S2
Benign
0.63
T
M_CAP
Benign
0.0039
T
MetaRNN
Benign
0.027
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.63
N
PhyloP100
-1.1
PrimateAI
Benign
0.30
T
PROVEAN
Benign
0.12
N
REVEL
Benign
0.072
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.087
MVP
0.21
MPC
0.74
ClinPred
0.0062
T
GERP RS
-7.0
Varity_R
0.048
gMVP
0.38
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375440229; hg19: chr7-124532380; COSMIC: COSV62928178; COSMIC: COSV62928178; API